SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-017103
Filing Date
2020-07-09
Accepted
2020-07-09 17:03:15
Documents
3
Period of Report
2020-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124009-8k_elitepharma.htm 8-K 29640
2 PURCHASE AGREEMENT, DATED JULY 8, 2020, BY AND BETWEEN THE COMPANY AND LINCOLN P ea124009ex10-1_elitepharma.htm EX-10.1 233941
3 REGISTRATION RIGHTS AGREEMENT, DATED JULY 8, 2020, BY AND BETWEEN THE COMPANY AN ea124009ex10-2_elitepharma.htm EX-10.2 90314
  Complete submission text file 0001213900-20-017103.txt   355150
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 201021059
SIC: 2834 Pharmaceutical Preparations